REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 159 filers reported holding REATA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $643,000 | +54.6% | 25,600 | +86.9% | 0.00% | +50.0% |
| Q2 2022 | $416,000 | -55.3% | 13,700 | +48.3% | 0.00% | -33.3% |
| Q3 2021 | $930,000 | -32.7% | 9,235 | -5.5% | 0.00% | -40.0% |
| Q2 2021 | $1,382,000 | -63.7% | 9,768 | -74.4% | 0.01% | -70.6% |
| Q1 2021 | $3,803,000 | +37.6% | 38,140 | +70.6% | 0.02% | +41.7% |
| Q4 2020 | $2,764,000 | -25.7% | 22,355 | -48.7% | 0.01% | -14.3% |
| Q1 2019 | $3,722,000 | -5.6% | 43,543 | -38.1% | 0.01% | -22.2% |
| Q4 2018 | $3,944,000 | – | 70,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $110,053,269 | 27.64% |
| Ghost Tree Capital, LLC | 500,000 | $18,995,000 | 8.11% |
| First Light Asset Management, LLC | 2,062,453 | $78,352,589 | 7.27% |
| Boxer Capital, LLC | 1,230,004 | $46,727,852 | 2.46% |
| Sofinnova Investments, Inc. | 992,029 | $37,687,182 | 2.24% |
| Tri Locum Partners LP | 141,466 | $5,374,000 | 2.17% |
| MPM BioImpact LLC | 194,181 | $7,376,936 | 1.91% |
| Ikarian Capital, LLC | 201,200 | $7,643,588 | 1.84% |
| KRS Capital Management, LLC | 28,141 | $1,069,077 | 1.46% |
| EMERALD ADVISERS, LLC | 679,772 | $25,824,538 | 1.25% |